世界の速効型インスリン市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Rapid Acting Insulins Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12642 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、速効型インスリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。速効型インスリンの種類別市場規模（リスプロ、アスパルト（NovoLog）、グルリジン（Apidra））、用途別市場規模（1型糖尿病、2型糖尿病）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・速効型インスリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly、Novo Nordisk、Sanofi ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：リスプロ、アスパルト（NovoLog）、グルリジン（Apidra） ・用途別分析2016年-2026年：1型糖尿病、2型糖尿病 ・速効型インスリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・速効型インスリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・速効型インスリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・速効型インスリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・速効型インスリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Rapid Acting Insulins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Rapid Acting Insulins size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Rapid Acting Insulins market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Rapid Acting Insulins market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Lispro
Aspart (NovoLog)
Glulisine (Apidra)

Market segment by Application, can be divided into
Type 1 Diabetes
Type 2 Diabetes

Market segment by players, this report covers
Eli Lilly
Novo Nordisk
Sanofi

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Rapid Acting Insulins
1.2 Classification of Rapid Acting Insulins by Type
1.2.1 Overview: Global Rapid Acting Insulins Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Rapid Acting Insulins Revenue Market Share by Type in 2020
1.2.3 Lispro
1.2.4 Aspart (NovoLog)
1.2.5 Glulisine (Apidra)
1.3 Global Rapid Acting Insulins Market by Application
1.3.1 Overview: Global Rapid Acting Insulins Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Rapid Acting Insulins Market Size & Forecast
1.5 Global Rapid Acting Insulins Market Size and Forecast by Region
1.5.1 Global Rapid Acting Insulins Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Rapid Acting Insulins Market Size by Region, (2016-2021)
1.5.3 North America Rapid Acting Insulins Market Size and Prospect (2016-2026)
1.5.4 Europe Rapid Acting Insulins Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Rapid Acting Insulins Market Size and Prospect (2016-2026)
1.5.6 South America Rapid Acting Insulins Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Rapid Acting Insulins Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Rapid Acting Insulins Market Drivers
1.6.2 Rapid Acting Insulins Market Restraints
1.6.3 Rapid Acting Insulins Trends Analysis
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Rapid Acting Insulins Product and Solutions
2.1.4 Eli Lilly Rapid Acting Insulins Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Eli Lilly Recent Developments and Future Plans
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk Rapid Acting Insulins Product and Solutions
2.2.4 Novo Nordisk Rapid Acting Insulins Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novo Nordisk Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Rapid Acting Insulins Product and Solutions
2.3.4 Sanofi Rapid Acting Insulins Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sanofi Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Rapid Acting Insulins Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Rapid Acting Insulins Players Market Share
3.2.2 Top 10 Rapid Acting Insulins Players Market Share
3.2.3 Market Competition Trend
3.3 Rapid Acting Insulins Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Rapid Acting Insulins Revenue and Market Share by Type (2016-2021)
4.2 Global Rapid Acting Insulins Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Rapid Acting Insulins Revenue Market Share by Application (2016-2021)
5.2 Rapid Acting Insulins Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Rapid Acting Insulins Revenue by Type (2016-2026)
6.2 North America Rapid Acting Insulins Revenue by Application (2016-2026)
6.3 North America Rapid Acting Insulins Market Size by Country
6.3.1 North America Rapid Acting Insulins Revenue by Country (2016-2026)
6.3.2 United States Rapid Acting Insulins Market Size and Forecast (2016-2026)
6.3.3 Canada Rapid Acting Insulins Market Size and Forecast (2016-2026)
6.3.4 Mexico Rapid Acting Insulins Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Rapid Acting Insulins Revenue by Type (2016-2026)
7.2 Europe Rapid Acting Insulins Revenue by Application (2016-2026)
7.3 Europe Rapid Acting Insulins Market Size by Country
7.3.1 Europe Rapid Acting Insulins Revenue by Country (2016-2026)
7.3.2 Germany Rapid Acting Insulins Market Size and Forecast (2016-2026)
7.3.3 France Rapid Acting Insulins Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Rapid Acting Insulins Market Size and Forecast (2016-2026)
7.3.5 Russia Rapid Acting Insulins Market Size and Forecast (2016-2026)
7.3.6 Italy Rapid Acting Insulins Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Rapid Acting Insulins Revenue by Type (2016-2026)
8.2 Asia-Pacific Rapid Acting Insulins Revenue by Application (2016-2026)
8.3 Asia-Pacific Rapid Acting Insulins Market Size by Region
8.3.1 Asia-Pacific Rapid Acting Insulins Revenue by Region (2016-2026)
8.3.2 China Rapid Acting Insulins Market Size and Forecast (2016-2026)
8.3.3 Japan Rapid Acting Insulins Market Size and Forecast (2016-2026)
8.3.4 South Korea Rapid Acting Insulins Market Size and Forecast (2016-2026)
8.3.5 India Rapid Acting Insulins Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Rapid Acting Insulins Market Size and Forecast (2016-2026)
8.3.7 Australia Rapid Acting Insulins Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Rapid Acting Insulins Revenue by Type (2016-2026)
9.2 South America Rapid Acting Insulins Revenue by Application (2016-2026)
9.3 South America Rapid Acting Insulins Market Size by Country
9.3.1 South America Rapid Acting Insulins Revenue by Country (2016-2026)
9.3.2 Brazil Rapid Acting Insulins Market Size and Forecast (2016-2026)
9.3.3 Argentina Rapid Acting Insulins Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Rapid Acting Insulins Revenue by Type (2016-2026)
10.2 Middle East & Africa Rapid Acting Insulins Revenue by Application (2016-2026)
10.3 Middle East & Africa Rapid Acting Insulins Market Size by Country
10.3.1 Middle East & Africa Rapid Acting Insulins Revenue by Country (2016-2026)
10.3.2 Turkey Rapid Acting Insulins Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Rapid Acting Insulins Market Size and Forecast (2016-2026)
10.3.4 UAE Rapid Acting Insulins Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Rapid Acting Insulins Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Rapid Acting Insulins Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Rapid Acting Insulins Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Rapid Acting Insulins Revenue (USD Million) by Region (2016-2021)
Table 5. Global Rapid Acting Insulins Revenue Market Share by Region (2021-2026)
Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 7. Eli Lilly Major Business
Table 8. Eli Lilly Rapid Acting Insulins Product and Solutions
Table 9. Eli Lilly Rapid Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 11. Novo Nordisk Major Business
Table 12. Novo Nordisk Rapid Acting Insulins Product and Solutions
Table 13. Novo Nordisk Rapid Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sanofi Corporate Information, Head Office, and Major Competitors
Table 15. Sanofi Major Business
Table 16. Sanofi Rapid Acting Insulins Product and Solutions
Table 17. Sanofi Rapid Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Global Rapid Acting Insulins Revenue (USD Million) by Players (2019-2021)
Table 19. Global Rapid Acting Insulins Revenue Share by Players (2019-2021)
Table 20. Breakdown of Rapid Acting Insulins by Company Type (Tier 1, Tier 2 and Tier 3)
Table 21. Rapid Acting Insulins Players Head Office, Products and Services Provided
Table 22. Rapid Acting Insulins Mergers & Acquisitions in the Past Five Years
Table 23. Rapid Acting Insulins New Entrants and Expansion Plans
Table 24. Global Rapid Acting Insulins Revenue (USD Million) by Type (2016-2021)
Table 25. Global Rapid Acting Insulins Revenue Share by Type (2016-2021)
Table 26. Global Rapid Acting Insulins Revenue Forecast by Type (2021-2026)
Table 27. Global Rapid Acting Insulins Revenue by Application (2016-2021)
Table 28. Global Rapid Acting Insulins Revenue Forecast by Application (2021-2026)
Table 29. North America Rapid Acting Insulins Revenue by Type (2016-2021) & (USD Million)
Table 30. North America Rapid Acting Insulins Revenue by Type (2021-2026) & (USD Million)
Table 31. North America Rapid Acting Insulins Revenue by Application (2016-2021) & (USD Million)
Table 32. North America Rapid Acting Insulins Revenue by Application (2021-2026) & (USD Million)
Table 33. North America Rapid Acting Insulins Revenue by Country (2016-2021) & (USD Million)
Table 34. North America Rapid Acting Insulins Revenue by Country (2021-2026) & (USD Million)
Table 35. Europe Rapid Acting Insulins Revenue by Type (2016-2021) & (USD Million)
Table 36. Europe Rapid Acting Insulins Revenue by Type (2021-2026) & (USD Million)
Table 37. Europe Rapid Acting Insulins Revenue by Application (2016-2021) & (USD Million)
Table 38. Europe Rapid Acting Insulins Revenue by Application (2021-2026) & (USD Million)
Table 39. Europe Rapid Acting Insulins Revenue by Country (2016-2021) & (USD Million)
Table 40. Europe Rapid Acting Insulins Revenue by Country (2021-2026) & (USD Million)
Table 41. Asia-Pacific Rapid Acting Insulins Revenue by Type (2016-2021) & (USD Million)
Table 42. Asia-Pacific Rapid Acting Insulins Revenue by Type (2021-2026) & (USD Million)
Table 43. Asia-Pacific Rapid Acting Insulins Revenue by Application (2016-2021) & (USD Million)
Table 44. Asia-Pacific Rapid Acting Insulins Revenue by Application (2021-2026) & (USD Million)
Table 45. Asia-Pacific Rapid Acting Insulins Revenue by Region (2016-2021) & (USD Million)
Table 46. Asia-Pacific Rapid Acting Insulins Revenue by Region (2021-2026) & (USD Million)
Table 47. South America Rapid Acting Insulins Revenue by Type (2016-2021) & (USD Million)
Table 48. South America Rapid Acting Insulins Revenue by Type (2021-2026) & (USD Million)
Table 49. South America Rapid Acting Insulins Revenue by Application (2016-2021) & (USD Million)
Table 50. South America Rapid Acting Insulins Revenue by Application (2021-2026) & (USD Million)
Table 51. South America Rapid Acting Insulins Revenue by Country (2016-2021) & (USD Million)
Table 52. South America Rapid Acting Insulins Revenue by Country (2021-2026) & (USD Million)
Table 53. Middle East & Africa Rapid Acting Insulins Revenue by Type (2016-2021) & (USD Million)
Table 54. Middle East & Africa Rapid Acting Insulins Revenue by Type (2021-2026) & (USD Million)
Table 55. Middle East & Africa Rapid Acting Insulins Revenue by Application (2016-2021) & (USD Million)
Table 56. Middle East & Africa Rapid Acting Insulins Revenue by Application (2021-2026) & (USD Million)
Table 57. Middle East & Africa Rapid Acting Insulins Revenue by Country (2016-2021) & (USD Million)
Table 58. Middle East & Africa Rapid Acting Insulins Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Rapid Acting Insulins Picture
Figure 2. Global Rapid Acting Insulins Revenue Market Share by Type in 2020
Figure 3. Lispro
Figure 4. Aspart (NovoLog)
Figure 5. Glulisine (Apidra)
Figure 6. Rapid Acting Insulins Revenue Market Share by Application in 2020
Figure 7. Type 1 Diabetes Picture
Figure 8. Type 2 Diabetes Picture
Figure 9. Global Rapid Acting Insulins Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Rapid Acting Insulins Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Rapid Acting Insulins Revenue Market Share by Region (2016-2026)
Figure 12. Global Rapid Acting Insulins Revenue Market Share by Region in 2020
Figure 13. North America Rapid Acting Insulins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Rapid Acting Insulins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Rapid Acting Insulins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Rapid Acting Insulins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Rapid Acting Insulins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Rapid Acting Insulins Market Drivers
Figure 19. Rapid Acting Insulins Market Restraints
Figure 20. Rapid Acting Insulins Market Trends
Figure 21. Eli Lilly Recent Developments and Future Plans
Figure 22. Novo Nordisk Recent Developments and Future Plans
Figure 23. Sanofi Recent Developments and Future Plans
Figure 24. Global Rapid Acting Insulins Revenue Share by Players in 2020
Figure 25. Rapid Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 26. Global Top 3 Players Rapid Acting Insulins Revenue Market Share in 2020
Figure 27. Global Top 10 Players Rapid Acting Insulins Revenue Market Share in 2020
Figure 28. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 29. Global Rapid Acting Insulins Revenue Share by Type in 2020
Figure 30. Global Rapid Acting Insulins Market Share Forecast by Type (2021-2026)
Figure 31. Global Rapid Acting Insulins Revenue Share by Application in 2020
Figure 32. Global Rapid Acting Insulins Market Share Forecast by Application (2021-2026)
Figure 33. North America Rapid Acting Insulins Sales Market Share by Type (2016-2026)
Figure 34. North America Rapid Acting Insulins Sales Market Share by Application (2016-2026)
Figure 35. North America Rapid Acting Insulins Revenue Market Share by Country (2016-2026)
Figure 36. United States Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Canada Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Mexico Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Europe Rapid Acting Insulins Sales Market Share by Type (2016-2026)
Figure 40. Europe Rapid Acting Insulins Sales Market Share by Application (2016-2026)
Figure 41. Europe Rapid Acting Insulins Revenue Market Share by Country (2016-2026)
Figure 42. Germany Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. France Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. United Kingdom Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Russia Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Italy Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Rapid Acting Insulins Sales Market Share by Type (2016-2026)
Figure 48. Asia-Pacific Rapid Acting Insulins Sales Market Share by Application (2016-2026)
Figure 49. Asia-Pacific Rapid Acting Insulins Revenue Market Share by Region (2016-2026)
Figure 50. China Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Japan Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. South Korea Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. India Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Southeast Asia Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Australia Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South America Rapid Acting Insulins Sales Market Share by Type (2016-2026)
Figure 57. South America Rapid Acting Insulins Sales Market Share by Application (2016-2026)
Figure 58. South America Rapid Acting Insulins Revenue Market Share by Country (2016-2026)
Figure 59. Brazil Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Argentina Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Middle East and Africa Rapid Acting Insulins Sales Market Share by Type (2016-2026)
Figure 62. Middle East and Africa Rapid Acting Insulins Sales Market Share by Application (2016-2026)
Figure 63. Middle East and Africa Rapid Acting Insulins Revenue Market Share by Country (2016-2026)
Figure 64. Turkey Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Saudi Arabia Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. UAE Rapid Acting Insulins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Methodology
Figure 68. Research Process and Data Source

---